Wednesday, June 22nd, 2016 - WiseGuyReports adds“Renal Biomarkers 2016 Global Market Opportunities and Forecasts 2022”reports to its database.


Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications. There is an impending need for specific and sensitive biomarkers that can identify kidney diseases at the earliest. The early identification helps to take timely preventive steps, before the damage becomes irreversible. The major factors fuelling the global renal biomarkers market are; increased incidence of kidney diseases, large geriatric population and increasing prevalence of multiple co-morbidities. The market would also gain prominence due to rising incidences of chronic diseases such as diabetes, obesity and hypertension, as these diseases are often associated with the gradual loss of kidney function. Furthermore, increasing investments in research and development will further drive the market, as renal biomarkers are widely used in preclinical and clinical trials, to assess the safety of new drugs. However, lack of transparent reimbursement and regulatory scenario, especially, in the developing countries, is likely to restrain the market.

The global renal biomarkers market is segmented on the basis of marker type, assay platform, application and geography. On the basis of marker type, the market is segmented into Creatinine, Blood urea nitrogen (BUN), Cystatin C, Neutrophil gelatinise-associated lipocalin (NGAL). It is further segmented into other markers such as N-Acetyl-?-D-Glucosaminidase (NAG), Kidney Injury Molecule 1 (Kim1), TIMP-2, L-FABP, Interleukin-18 and Clusterin. The market is segmented on the basis of assay platform type into, Enzyme Linked Immunosorbent Assay (ELISA) and Turbidimetric Immunoassay which includes Particle-Enhanced Turbidimetric Immunoassay (PETIA). The market further segments into other assay types such as Chemiluminescent Immunoassay (CLIA) and fluorescence immunoassay. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and LAMEA.

For more information or any query mail at [email protected]     

Few of the strategies adopted by key industrial players are collaborations, FDA approvals and distribution agreements. For instance, recently, the International Society of Nephrology (ISN) with the support of industry players, has launched, 0by25, a human right initiative to neutralize the count of deaths arising from acute kidney injury, worldwide, by 2025. In Sep 2014, FDA approved Astute Medical’s NephroCheck, the first diagnostic test for acute kidney injury. The company also entered into a marketing and development agreement with BioMérieux, allowing the use of NephroCheck on VIDAS immunoassay system. The companies profiled in the report include, Abbott Diagnostics, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Siemens Healthcare Diagnostics Inc., Thermo Fisher Scientific Inc., Astute Medical Inc., Alere Inc., bioMérieux SA and Randox Laboratories Ltd.


Comprehensive analysis of factors that drive and restrict the growth of the global renal biomarkers market is provided

The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014-2020, which would enable the stakeholders to capitalize on prevailing Market - Opportunities

An in-depth analysis of key segments of the market demonstrate the types of markers and assay platforms that are currently being used along with the variants that would gain prominence in future

SWOT analysis enables to study the internal environment of the leading companies for strategy formulation

Region-wise renal biomarkers market conditions are comprehensively analyzed in the report

Competitive intelligence highlights the business practises followed by leading market players across the geographies

The global renal biomarkers market is segmented below:

Global Renal Biomarkers Market - By Marker Type


Blood urea nitrogen (BUN)

Cystatin C

Neutrophil gelatinase-associated lipocalin (NGAL)



N-Acetyl-?-D-Glucosaminidase (NAG)

Kidney Injury Molecule 1 (Kim1)

TIMP-2 (TIMP metallopeptidase inhibitor 2)

Liver-Type Fatty Acid-Binding Protein (L-FABP)

Interleukin-18 (IL-18)


Global Renal Biomarkers Market - By Assay Platform Type

Enzyme Linked Immunosorbent Assay (ELISA)

Enzymatic Assay

Turbidimetric Immunoassay

Particle-Enhanced Turbidimetric Immunoassay (PETIA)


Chemiluminescent Immunoassay (CLIA)

Fluorescence Immunoassay

Global Renal Biomarkers Market - By Application

Diagnosis and disease progression monitoring


Global Renal Biomarkers Market - By Geography

North America




Research Methodology

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.



For more information or any query mail at [email protected]

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Renal Biomarkers,Renal Biomarkers Industry,Renal Biomarkers Market,Renal Biomarkers Market Trend,Renal Biomarkers Industry Trends,Renal Biomarkers Market Share,Renal Biomarkers Market Growth,Renal Biomarkers Market Size,Renal Biomarkers Manufacturer,Renal




More Formats